ORTHOCELL LTD(ASX:OCC)
Company Profile:
Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes CelGro, Striate+, Remplir, and SmrtGraft. CelGro is a collagen medical device that facilitates tissue
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Penny Stock Spotlight Report
A$399.00
Already a subscriber?
Sign in to read this report.
Required subscription
Penny Stock Spotlight Report
Explore emerging ASX penny stock opportunities through weekly research focused on early-stage companies, growth catalysts, and high-risk, high-potential investment ideas.
- ✓ Exclusive Weekly Penny Stock Research
- ✓ Delivered Every Monday
- ✓ Risk Rating: High Risk, High Reward
- ✓ Full Historical Report Access
A$399.00A$1500.00/ 12 months
Risk:High
Subscribe Now →
